Depreciation of DICE Therapeutics, Inc. from 31 Mar 2021 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
DICE Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2021 to 31 Mar 2023.
  • DICE Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2023 was $244,000, a 62% increase year-over-year.
  • DICE Therapeutics, Inc. annual Depreciation for 2022 was $825,000, a 25% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

DICE Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $244,000 +$93,000 +62% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q1 2022 $151,000 -$29,000 -16% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $180,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1

DICE Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $825,000 +$164,000 +25% 01 Jan 2022 31 Dec 2022 10-K 15 Mar 2023 2022 FY
2021 $661,000 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.